Did You Suffer Losses in Perrigo Company plc (PRGO)? Contact Levi & Korsinsky About Securities Fraud ClaimsNovember 13, 2025 3:32 PM EST | Source: Levi & Korsinsky, LLPNew York, New York--(Newsfile Corp. - November 13, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Perrigo Company plc ("Perrigo Company plc") (NYSE: PRGO) concerning possible violations of federal securities laws.Perrigo issued a press release on November 5, 2025, "announc[ing] that it is i ...

Core Viewpoint - A class action securities lawsuit has been filed against Cytokinetics, Incorporated, alleging securities fraud that affected shareholders between December 27, 2023, and May 6, 2025 [2]. Group 1: Lawsuit Details - The lawsuit claims that Cytokinetics made materially false and misleading statements regarding the timeline for the New Drug Application (NDA) submission and approval process for aficamten [3]. - Defendants indicated that they expected FDA approval for aficamten's NDA in the second half of 2025, based on a PDUFA date of September 26, 2025, while failing to disclose risks related to the omission of a Risk Evaluation and Mitigation Strategy (REMS) [3][4]. - During an earnings call on May 6, 2025, it was disclosed that the company had multiple pre-NDA meetings with the FDA but chose to submit the NDA without a REMS, misleading investors about the regulatory timeline [4]. Group 2: Impact on Shareholders - As a result of the alleged false statements, shareholders purchased Cytokinetics' common stock at inflated prices and incurred significant losses when the truth about the NDA submission was revealed [5]. - Shareholders who suffered losses during the relevant timeframe are encouraged to seek recovery, with no cost or obligation to participate [6]. Group 3: Legal Representation - Levi & Korsinsky LLP, a nationally recognized securities litigation firm, has a strong track record in securing recoveries for shareholders and has been ranked among the top securities litigation firms in the United States for seven consecutive years [7].

Core Viewpoint - Ardent Health, Inc. is under investigation for potential violations of federal securities laws following a significant revenue drop and a 33% decline in stock price [1][3][4]. Financial Performance - In Q3 2025, Ardent reported a $43 million decrease in revenue due to "hindsight evaluations of historical collection trends" [4]. - The company also increased its professional liability reserves by $54 million due to adverse prior period claim developments from 2019 to 2022 and broader industry trends [4]. Stock Market Reaction - Following the financial results announcement on November 12, 2025, Ardent's stock price fell over 33% during trading on November 13, 2025 [4]. Legal Implications - Bleichmar Fonti & Auld LLP has initiated an investigation into Ardent Health, Inc. for potential securities fraud, urging affected investors to contact them for more information [1][2][5].

Core Viewpoint - A class action lawsuit has been filed against Stride, Inc. for allegedly misleading investors regarding its operations and financial performance during the specified Class Period from October 22, 2024, to October 28, 2025 [1][3]. Company Overview - Stride, Inc. is an education technology company based in Reston, Virginia, providing online learning programs, curricula, and support services to schools and districts across the United States [2]. Allegations - The lawsuit claims that Stride inflated enrollment numbers, reduced staffing below statutory limits, ignored compliance requirements, and concealed enrollment losses during the Class Period [3]. - The truth about Stride's situation was revealed on September 14, 2025, when a school district sued the company for fraud and deceptive trade practices [4]. - On October 28, 2025, Stride announced that "poor customer experience" led to increased withdrawal rates and decreased enrollments, which significantly impacted the company's stock price [4].

Core Viewpoint - A class action lawsuit has been filed against KBR, Inc. for allegedly making false and misleading statements regarding its partnership with HomeSafe, which led to a significant drop in KBR's stock price after the termination of a contract by the U.S. Department of Defense's TRANSCOM [1][3][4]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who acquired KBR shares between May 6, 2025, and June 19, 2025 [1][2]. - Investors have until November 18, 2025, to seek appointment as lead plaintiff representatives [2]. - The allegations include KBR's failure to disclose concerns from TRANSCOM about HomeSafe's ability to fulfill its obligations under the Global Household Goods Contract [3]. Group 2: Impact on Stock Price - Following the announcement of the contract termination by HomeSafe on June 19, 2025, KBR's shares fell by $3.85, or 7%, closing at $48.93 on June 20, 2025 [4]. Group 3: Company Background - KBR, Inc. is headquartered in Houston, Texas, and provides engineering, logistics, defense contracting, and mission-critical government services [2].

Core Viewpoint - Kehoe Law Firm, P.C. is investigating potential breaches of fiduciary duties by certain board members and executive officers of Priority Technology Holdings, Inc. in relation to a proposal to take the company private at a price below market value [1][2]. Group 1: Investigation Details - The investigation centers on a proposal by CEO Thomas Priore to acquire publicly held shares of Priority Technology for $6.00-$6.15 per share [2]. - This proposed price is significantly lower than the company's 52-week average price of $8.19 and high price of $12.47, as well as below the average and high Street price targets of $10.80 and $13.00, respectively [3]. Group 2: Company Background - Priority Technology Holdings, Inc. is publicly traded on NASDAQ under the ticker PRTH [2]. - Kehoe Law Firm, P.C. is a recognized plaintiff-side class action firm that focuses on protecting investors and consumers from fraud and misconduct, having recovered over $10 billion for investors [3][4].

Core Viewpoint - A class action lawsuit has been filed against Stride, Inc. for alleged violations of federal securities laws, focusing on misleading statements regarding the company's products and services [1][2]. Class Definition - The lawsuit seeks damages for all individuals and entities that purchased Stride securities between October 22, 2024, and October 28, 2025, inclusive [2]. Case Details - The Complaint alleges that Stride made misleading statements about its educational products and services, claiming they help learners reach their full potential while engaging in practices such as: - Inflating enrollment numbers by retaining "ghost students" - Cutting staffing costs by overloading teachers beyond statutory limits - Ignoring compliance requirements, including background checks and special education services - Suppressing whistleblowers who reported financial directives to delay hiring and deny services - Losing existing and potential enrollments [3]. Next Steps - Interested parties can review the Complaint and have until January 12, 2026, to request appointment as lead plaintiff, although participation in any recovery does not require this role [4]. Legal Representation - The law firm Bronstein, Gewirtz & Grossman, LLC operates on a contingency fee basis, meaning they will only collect fees if the lawsuit is successful [5].

Core Viewpoint - Stride, Inc. is facing a securities class action lawsuit from shareholders due to significant operational and compliance challenges that have led to a sharp decline in its stock price [1] Group 1: Legal Proceedings - Hagens Berman, a prominent shareholder rights law firm, is investigating legal claims against Stride and its executives, urging affected investors to report their losses [2] - The class action lawsuit covers the period from October 22, 2024, to October 28, 2025, with a lead plaintiff deadline set for January 12, 2026 [3] - The litigation focuses on Stride's assurances regarding its business model and enrollment figures, particularly after the loss of a contract with Gallup-McKinley [3] Group 2: Allegations and Findings - The complaint alleges that Stride misled investors about its operational health, including inflated enrollment figures by including "ghost students" and increasing student-to-teacher ratios unlawfully [4][9] - A report surfaced on September 14, 2025, revealing Gallup-McKinley's lawsuit against Stride for fraud and deceptive practices, which further damaged investor trust [4] - Stride's announcement on October 28, 2025, indicated that "poor customer experience" led to an estimated loss of 10,000 to 15,000 enrollments [5] Group 3: Financial Outlook - Investors expressed significant concern over Stride's guidance for 2026, forecasting only 5% sales growth, a stark decline from the previous five years' annualized growth of 19% [6]

New York, New York--(Newsfile Corp. - November 13, 2025) - If you suffered a loss on your Inspire Medical Systems, Inc. (NYSE: INSP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/inspire-medical-systems-inc-lawsuit-submission-form?prid=177137&wire=5&utm_campaign=5or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareho ...

Core Viewpoint - A class action lawsuit has been filed against Stride, Inc. for securities fraud, following significant stock drops attributed to potential violations of federal securities laws [1][2]. Company Overview - Stride, Inc. is an education technology company that provides an online platform for students across the U.S. [3]. Allegations - The lawsuit claims that Stride inflated enrollment numbers by retaining "ghost students," failed to comply with employee background checks and licensure laws, and provided a poor customer experience leading to higher withdrawal rates and lower conversion rates [3][4]. Stock Performance - On September 14, 2025, Stride's stock dropped by $18.60, or over 11%, from $158.36 to $139.76 per share following the fraud allegations [4]. - On October 28, 2025, Stride admitted to poor customer experiences, resulting in an estimated 10,000-15,000 fewer enrollments, causing the stock to plummet by $83.48, or more than 54%, from $153.53 to $70.05 per share [5]. Legal Proceedings - Investors have until January 12, 2026, to request to lead the case in the U.S. District Court for the Eastern District of Virginia [2].